Bio-Path Holdings Inc (BPTH)
2.63
+0.14
(+5.62%)
USD |
NASDAQ |
Apr 25, 16:00
2.63
0.00 (0.00%)
After-Hours: 20:00
Bio-Path Holdings Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.00 |
| June 30, 2008 | 0.00 |
| March 31, 2008 | 0.00 |
| December 31, 2007 | -0.1784 |
| September 30, 2007 | -0.3803 |
| June 30, 2007 | -0.4315 |
| March 31, 2007 | -0.6719 |
| December 31, 2006 | -1.003 |
| September 30, 2006 | -1.065 |
| June 30, 2006 | -1.336 |
| March 31, 2006 | -3.207 |
| December 31, 2005 | 35.50 |
| September 30, 2005 | 6.129 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| EyePoint Pharmaceuticals Inc | 0.00 |
| INVO Bioscience Inc | 3.096 |
| SINTX Technologies Inc | 0.0052 |
| Aileron Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.3431 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.22M |
| Total Liabilities (Quarterly) | 2.779M |
| Shareholders Equity (Quarterly) | 0.441M |